{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:09:24Z","timestamp":1791882564981,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ijrobp.2012.08.017","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T05:00:39Z","timestamp":1349240439000},"page":"e7-e13","source":"Crossref","is-referenced-by-count":41,"title":["Postmastectomy Hypofractionated and Accelerated Radiation Therapy With (and Without) Subcutaneous Amifostine Cytoprotection"],"prefix":"10.1016","volume":"85","author":[{"given":"Michael I.","family":"Koukourakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianthi","family":"Panteliadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis M.","family":"Abatzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Sismanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Sivridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Giatromanolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2012.08.017_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ijrobp.2008.10.080","article-title":"ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast","volume":"73","author":"Taylor","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.radonc.2008.09.026","article-title":"Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: a systematic review","volume":"91","author":"Rowell","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.radonc.2007.02.001","article-title":"Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 B&C randomized trials","volume":"82","author":"Overgaard","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib4","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2007.14.5565","article-title":"Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group","volume":"26","author":"Kyndi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0360-3016(01)01759-X","article-title":"Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients","volume":"52","author":"Koukourakis","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ijrobp.2008.09.016","article-title":"Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report","volume":"74","author":"Koukourakis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib10","unstructured":"www.accessdata.fda.gov\/scripts\/cder\/onctools\/toxcrit2.cfm."},{"key":"10.1016\/j.ijrobp.2012.08.017_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-8140(95)90055-1","article-title":"LENT SOMA tables","volume":"35","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0167-8140(86)80061-5","article-title":"Alpha\/beta and the importance of the size of dose per fraction for late complications in the supraglottic larynx","volume":"7","author":"Macejewski","year":"1986","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ijrobp.2010.03.038","article-title":"Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy","volume":"80","author":"Wang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib14","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1200\/JCO.2010.33.4714","article-title":"Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy","volume":"29","author":"Abdulkarim","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib15","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1158\/1078-0432.CCR-06-0480","article-title":"CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance","volume":"12","author":"Brennan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib16","first-page":"6363","article-title":"Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients","volume":"9","author":"Manders","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2012.08.017_bib17","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612034037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612034037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T10:56:22Z","timestamp":1542711382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301612034037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0360301612034037"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2012.08.017","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}